ATXS
NASDAQ
US
Astria Therapeutics, Inc. - Common Stock
$12.58
+0.0 (+0.0%)
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$747.2M
ROE
-45.0%
D/E
0.00
Beta
0.20
52W
$4–$13
Wall Street Consensus
7 analysts · Apr 20260
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
VOR
Vor Biopharma Inc
$286.6M
SLS
Sellas Life Sciences Group Inc
$537.0M
MGTX
MeiraGTx Holdings PLC
$639.9M
SLDB
Solid Biosciences Inc
$439.4M
BBOT
BridgeBio Oncology Therapeutics Inc
P/E 212.3
$1.0B
REPL
Replimune Group Inc
$762.5M
DSGN
Design Therapeutics Inc
$534.3M
GYRE
Gyre Therapeutics Inc
P/E 96.5
$641.7M
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.66
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.66 | — | — |
| Sep 2025 | $-0.40 | $-0.55 | $-0.15 |
| Jun 2025 | $-0.60 | $-0.57 | +$0.03 |
| Mar 2025 | $-0.49 | $-0.58 | $-0.09 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -38.6% | -38.6% | -38.6% | -38.6% | -38.6% | -45.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 14.89 | 14.89 | 14.89 | 14.89 | 14.89 | 10.78 |
Key Ratios
ROA (TTM)
-41.1%
P/B
1.6
EPS (TTM)
$-2.14
CF/Share
$-0.69
52W High
$13.29
52W Low
$3.56
$3.56
52-Week Range
$13.29
How does ATXS compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ATXS valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.6
▼
36%
below
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ATXS profitability vs Biotechnology peers
ROE
-45.0%
▲
33%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-41.1%
▲
12%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
ATXS financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
10.8
▲
143%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.2
▼
80%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ATXS fundamentals radar
ATXS
Peer median
Industry
ATXS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ATXS vs peers: key metrics
Latest News
No related news yet